Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study
It belongs to a class of drugs known as multi-receptor agonists, and its mechanism of action is notably broad: it simultaneously activates three hormone receptors the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Esta combinacin tambin puede mejorar parmetros de fatiga crnica, claridad mental y te tolerancia al ejercicio , aspectos clave en la fibromialgia
Refer to our switching between GLP-1 formulations guide for additional context
Norman Swan : It was the telly
doi:10.3389/fendo.2022.945609 45